Estimates Revisions Virax Biolabs Group Limited

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 09/03/2026 GMT			5-day change	1st Jan Change
0.2000 ^USD	-6.76%		-9.21%	-42.16%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	VIRAX BIOLABS GROUP LIMITED
	LONZA GROUP AG
	BEONE MEDICINES AG
	CELLTRION, INC.
	IQVIA HOLDINGS INC.
	REVOLUTION MEDICINES, INC.
	ASCENDIS PHARMA A/S
	MEDPACE HOLDINGS, INC.
	EUROFINS SCIENTIFIC SE
	IONIS PHARMACEUTICALS, INC.
	Average
	Weighted average by Cap.